For myopia above -8.00D to -10.00D, EVO ICL is typically the best option. For prescriptions in the moderate-to-high range (-6.00D to -10.00D), both laser surgery and EVO ICL may be viable — and the choice depends on corneal anatomy.
This question is addressed throughout the Vision Correction Procedures Compared hub, particularly in the pages on Vision Correction for Nearsightedness (Myopia) and LASIK vs PRK vs EVO ICL: Complete Comparison.
Featured Snippet: Best Option by Prescription Level
| Prescription Range | First-Choice Option | Why | |——————-|———————|—–| | -1.00D to -6.00D | LASIK, PRK, or SMILE | All produce excellent results; choose based on anatomy and lifestyle | | -6.00D to -8.00D | LASIK or EVO ICL | Both viable; EVO ICL preferred if corneas are thin | | -8.00D to -12.00D | EVO ICL strongly preferred | Laser ablation at this range removes large amounts of tissue; optical quality and safety favor ICL | | Above -12.00D | EVO ICL or RLE | LASIK generally inadvisable; RLE if over 45 |
Why High Prescriptions Challenge Laser Surgery
Every diopter of myopia corrected by LASIK requires removing a specific amount of corneal tissue. At low prescriptions (-2.00D), this is modest. At -10.00D, the ablation volume is substantial.
Removing excessive tissue creates two problems:
Structural risk: The cornea must retain sufficient residual thickness to remain biomechanically stable. Insufficient residual stromal bed (the tissue beneath the flap) risks ectasia — progressive corneal thinning and distortion that is difficult to treat. This risk is why LASIK outcomes deteriorate above -8.00D in patients without generous baseline corneal thickness.
Optical quality: Large laser ablations produce larger treatment zones and more complex ablation profiles, which can introduce higher-order optical aberrations — increasing halos, glare, and starbursts, particularly in low-light conditions.
Why EVO ICL Excels at High Prescriptions
The EVO ICL corrects myopia without touching the cornea at all. It adds a corrective lens inside the eye — between the iris and the natural crystalline lens — that bends light precisely onto the retina.
Because it does not depend on tissue removal, there is no upper limit on treatable myopia from a biomechanical safety perspective. The FDA-approved range extends to -20.00D, and clinical outcomes at -12.00D to -15.00D with EVO ICL are consistently excellent.
Additionally, the optical quality of the Collamer lens material produces particularly clean, high-contrast vision — patients with high myopia who switch from thick glasses or high-powered contact lenses to EVO ICL frequently describe a dramatic improvement in the clarity and naturalness of their vision, particularly at night.
What About Hyperopia?
High hyperopia (above +4.00D) presents a different challenge. The EVO ICL is not FDA-approved for hyperopia in the US. Laser surgery for high hyperopia has meaningful regression rates. For patients with high hyperopia — especially those over 45 — Refractive Lens Exchange is typically the most appropriate solution.
Getting an Accurate Assessment
The only way to know definitively which procedure fits your prescription and anatomy is a pre-operative consultation with corneal measurements. Related answer pages:
- How Do I Know If I’m a Candidate for Any Vision Correction?
- Can I Get Vision Correction If I Have Dry Eyes?
- Which Vision Correction Is Safest?
*This content is educational and does not constitute medical advice.*